Skip to content
June 18, 2026
  • WB Asks Private Hospitals to Reserve 10% Beds for Free Treatment
  • Novartis India introduces Pluvicto, Country’s First Approved Radioligand Therapy for Advanced Prostate Cancer
  • Private Hospitals in India Lag Behind in Medical Research, Study Reveals
  • India Restricts Over-the-Counter Sale of Cough Syrups; Prescriptions Now Mandatory
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • AIDS

AIDS

HIV
  • Articles
  • Global Healthcare

“HIV Prevention Breakthrough: Revolutionary Lenacapavir Offers Hope, But Faces Accessibility Hurdles Due to High Costs”

tishha_newsSeptember 14, 2024September 14, 202407 mins

HIV Prevention Faces Challenges: Highly Effective Injectable Drug Lenacapavir Hindered by High Costs HIV prevention has reached a significant milestone…

Read More
SDG
  • Global Healthcare
  • News

Gujarat Tops Health Category in SDG India Index 2023-24

tishha_newsAugust 7, 2024August 7, 202406 mins

Overview of the SDG India Index The SDG India Index 2023-24, released by NITI Aayog last month, is the fourth…

Read More
AIDS_WHO
  • Articles
  • Global Healthcare

WHO at AIDS 25th International Conference: Unleashing Innovative Strategies and Groundbreaking Guidelines for a Healthier Future

tishha_newsJuly 20, 2024July 20, 202409 mins

The World Health Organization (WHO) is actively participating in the 25th International AIDS Conference (AIDS 2024) held in Munich, Germany,…

Read More
HIV
  • Global Healthcare
  • News

HIV Breakthrough: Drug Trial Shows Injection Twice a Year is 100% Effective

tishha_newsJuly 9, 2024July 9, 202418 mins

In a groundbreaking development, a recent drug trial has revealed that an injection administered twice a year is 100% effective…

Read More

Most Viewed

News
WB Asks Private Hospitals to Reserve 10% Beds for Free Treatment
Private hospitals in Kolkata have decided to seek a separate…
News
Novartis India introduces Pluvicto, Country’s First Approved Radioligand Therapy for Advanced Prostate Cancer
Novartis India has launched Pluvicto (lutetium-177 vipivotide tetraxetan), marking the…

Random

1

WB Asks Private Hospitals to Reserve 10% Beds for Free Treatment

  • News
2

Novartis India introduces Pluvicto, Country’s First Approved Radioligand Therapy for Advanced Prostate Cancer

  • News
3

Private Hospitals in India Lag Behind in Medical Research, Study Reveals

  • News
4

India Restricts Over-the-Counter Sale of Cough Syrups; Prescriptions Now Mandatory

  • News
5

IMA Bareilly Successfully Organised Voluntary Blood Donation and Stem Cell Donor Registration Camp on World Blood Donor Day

  • News
6

PM Modi to Lead International Yoga Day Main Event in Kolkata on June 21

  • News
7

Dr Lal PathLabs Sets Up Wholly Owned Dubai Subsidiary to Drive Global Expansion 

  • Expansion
  • Global Healthcare
8

Jupiter Life Line Hospitals Targets 3,000 Beds as Expansion Drive Gains Momentum

  • Expansion
  • Market Watch
tishha_logo
TISHHA News Developed By BlazeThemes.